Published in Transplantation on August 01, 1978
Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med (1981) 2.18
Long-term culture of normal mouse B lymphocytes. Proc Natl Acad Sci U S A (1981) 1.94
Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology (1982) 1.35
Cell surface expression of H2 antigens on primary sensory neurons in response to acute but not latent herpes simplex virus infection in vivo. J Virol (1999) 1.30
The surface phenotype of a suppressor cell of delayed-type hypersensitivity in the mouse. Immunology (1980) 0.83
An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions. Immunology (1982) 0.77
GPLA antigens are not expressed on guinea-pig epididymal spermatozoa. Clin Exp Immunol (1984) 0.75
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (1978) 6.59
Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun (1978) 3.24
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A (1998) 2.71
Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun (1978) 2.65
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. Science (1992) 2.41
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med (1979) 2.28
T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells. J Exp Med (1977) 2.22
Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med (1981) 2.18
Murine lymphocyte surface antigens. Adv Immunol (1979) 2.04
In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cell Immunol (1982) 1.97
A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera. J Immunol Methods (1978) 1.91
Restriction in adoptive transfer of resistance to Listeria monocytogenes. II. Use of congenic and mutant mice show transfer to be H-2K restricted. Cell Immunol (1983) 1.86
A high proportion of hybridomas raised to a plant extract secrete antibody to arabinose or galactose. Plant Physiol (1984) 1.84
The role of beta 2-microglobulin in peptide binding by class I molecules. Science (1990) 1.80
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A (1993) 1.76
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med (1995) 1.70
Which T cells cause graft rejection? Transplantation (1982) 1.69
Listeria monocytogenes infects human endothelial cells by two distinct mechanisms. Infect Immun (1995) 1.68
"B"-cell stimulation of allogeneic T-cell proliferation in mixed lymphocyte cultures. Nat New Biol (1973) 1.68
Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol (1992) 1.64
Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc Natl Acad Sci U S A (1990) 1.59
MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nat Med (1998) 1.58
Mouse macrophage beta subunit (CD11b) cDNA for the CR3 complement receptor/Mac-1 antigen. Immunogenetics (1990) 1.58
Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52
Ir gene function in an I-A subregion mutant B6.C-H-2bm12. J Exp Med (1981) 1.51
Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization. J Exp Med (1996) 1.49
Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses. J Immunol (1980) 1.48
Tissue expression, structure and function of the murine Ly-6 family of molecules. Immunol Cell Biol (1995) 1.48
Detection and significance of occult metastases in node-negative breast cancer. Br J Surg (1993) 1.47
Inhibition of hyperacute transplant rejection by soluble proteins with the functional domains of CD46 and FcgammaRII. Transplantation (2000) 1.46
Peptide mimics of a tumor antigen induce functional cytotoxic T cells. Nat Biotechnol (1998) 1.46
The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology (1990) 1.45
Lesions in the blood supply of the papilla in experimental analgesic nephropathy. Med J Aust (1968) 1.42
Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J Immunol (1999) 1.41
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res (1991) 1.41
Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection. J Exp Med (1980) 1.41
Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J Clin Invest (1997) 1.40
Mitotic recombination between homologous chromosomes generates H-2 somatic cell variants in vitro. Proc Natl Acad Sci U S A (1987) 1.40
Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev (1994) 1.40
Mucins: structure, function, and associations with malignancy. Bioessays (1992) 1.40
Molecular cloning of a human immunoglobulin G Fc receptor. Proc Natl Acad Sci U S A (1988) 1.38
Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds. Proc Natl Acad Sci U S A (1986) 1.36
Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology (1982) 1.35
Deposits of immunoglobulin and fibrin in human allografted kidneys. Lancet (1968) 1.35
Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol (1977) 1.33
ABO blood group and related antigens, natural antibodies and transplantation. Tissue Antigens (2006) 1.32
Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol Immunol (1993) 1.32
Ly-4, a new locus determining a lymphocyte cell-surface alloantigen in mice. Proc Natl Acad Sci U S A (1973) 1.30
Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat Struct Biol (1999) 1.29
H-2 hemizygous mutants from a heterozygous cell line: role of mitotic recombination. EMBO J (1983) 1.28
Role of the mannose receptor in the immune response. Curr Mol Med (2001) 1.28
A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J Exp Med (1995) 1.28
Identification and quantification of complement regulator CD46 on normal human tissues. Immunology (1993) 1.28
Antibody production in immunosuppressed recipients of renal allografts. Lancet (1969) 1.28
Cooperation between mouse T-cell subpopulations in the cell-mediated response to a natural poxvirus pathogen. Cell Immunol (1976) 1.26
The Lyt-2 molecule recognizes residues in the class I alpha 3 domain in allogeneic cytotoxic T cell responses. J Exp Med (1988) 1.26
Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunol Cell Biol (1989) 1.23
Expression of H-2Db on the cell surface in the absence of detectable beta 2 microglobulin. J Exp Med (1984) 1.23
Cutaneous leishmaniasis in mice: disease patterns in reconstituted nude mice of several genotypes infected with Leishmania tropica. Aust J Exp Biol Med Sci (1980) 1.22
Hu Ly-m5: a unique antigen physically associated with HLA molecules. Hum Immunol (1983) 1.22
Arthroplasty of the knee in rheumatoid arthritis and osteoarthritis. A follow-up study after implantation of the McKeever and MacIntosh prostheses. J Bone Joint Surg Am (1972) 1.21
A genomic clone encoding the alpha chain of the OKM1, LFA-1, and platelet glycoprotein IIb-IIIa molecules. Proc Natl Acad Sci U S A (1986) 1.20
Mutation in the IA subregion of the murine H-2 complex. Immunogenetics (1980) 1.20
A new breast carcinoma antigen defined by a monoclonal antibody. J Natl Cancer Inst (1985) 1.20
Acute destruction by humoral antibody of rat skin grafted to mice. J Immunol (1973) 1.19
Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis. Transpl Immunol (1993) 1.19
Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation. J Immunol (1987) 1.18
Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation (1995) 1.17
The murine Fc receptor for immunoglobulin: purification, partial amino acid sequence, and isolation of cDNA clones. Proc Natl Acad Sci U S A (1986) 1.17
Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer (1994) 1.16
A human breast tissue-associated antigen detected by a monoclonal antibody. J Natl Cancer Inst (1983) 1.16
Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc Natl Acad Sci U S A (1995) 1.16
Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1. J Immunol (1980) 1.15
Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. J Immunol (1990) 1.14
The mouse Fc receptor for IgG (Ly-17): molecular cloning and specificity. Immunogenetics (1987) 1.13
Systemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice. Hum Gene Ther (1999) 1.11
Molecular analysis of an EL4 cell line that expresses H-2Db but not H-2Kb or beta 2-microglobulin. Proc Natl Acad Sci U S A (1985) 1.11
Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine (1996) 1.11
Measles virus receptor properties are shared by several CD46 isoforms differing in extracellular regions and cytoplasmic tails. J Gen Virol (1994) 1.10
MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines. Cancer Immunol Immunother (2000) 1.10
Variations in the responses of C57BL-10J and A-J mice to sheep red blood cells. J Exp Med (1972) 1.08
Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen. J Immunol (1997) 1.08
Comparative immunogenicity and enhanceability of individual H-2K and H-2D specificities of the murine histocompatibility-2 complex. J Exp Med (1973) 1.08
Cellular mucins: targets for immunotherapy. Crit Rev Immunol (1994) 1.08
Major histocompatibility gene complex (MHC)-coded determinants on antigen-specific suppressor factor for delayed-type hypersensitivity and surface phenotypes of cells producing the factor. Eur J Immunol (1980) 1.08
Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: its relationship with prognosis. Int J Cancer (1999) 1.08
Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal. Proc Natl Acad Sci U S A (1997) 1.08
Lesions in the vasa recta in experimental analgesic nephropathy. Lancet (1968) 1.07